Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Vaccination strategies, the po...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Vaccination strategies, the power of the unmatched double hits

Vaccination strategies, the power of the unmatched double hits

Bibliographic Details
Main Authors: Talal S Al-Qaisi, Berjas Abumsimir
Format: Article
Language:English
Published: Taylor & Francis Group 2023-10-01
Series:Future Science OA
Subjects:
heterologous vaccination
homologous vaccination
immune dominance
prime-boost vaccine
Online Access:https://www.future-science.com/doi/10.2144/fsoa-2023-0090
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.future-science.com/doi/10.2144/fsoa-2023-0090

Similar Items

  • The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine
    by: Surakameth Mahasirimongkol, et al.
    Published: (2022-03-01)
  • Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea
    by: Yunhyung Kwon, et al.
    Published: (2022-12-01)
  • Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
    by: Gabiria Pastore, et al.
    Published: (2024-12-01)
  • Heterologous vaccination (ChAdOx1 and BNT162b2) induces a better immune response against the omicron variant than homologous vaccination
    by: Jaeeun Yoo, et al.
    Published: (2023-10-01)
  • Antibody Response after Homologous and Heterologous Prime–Boost COVID-19 Vaccination in a Bangladeshi Residential University Cohort
    by: Nihad Adnan, et al.
    Published: (2024-04-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs